Sole Source Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR)
Closed Special Notice Posted
- Solicitation number
- HT941026N0046
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Tripler Army Medical Center, Hawaii 96859, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency (DHA), Healthcare Contracting Division-West, has published a Notice of Intent to award a sole source supply contract to Illumina, Inc. for Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits intended for Tripler Army Medical Center's Department of Clinical Investigation in Hawaii. This special notice was posted on April 14, 2026, and represents DHA's intention to procure equipment and supplies classified under NAICS code 541714 (Research and Development in Biotechnology) and PSC code 6550 (Medical Equipment and Accessories and Supplies). The procurement is justified as a sole source award because Illumina, Inc. is the exclusive vendor capable of providing sequencing supplies compatible with the Government-owned MiSeq Systems at the facility. This is not a request for competitive proposals, and no formal solicitation document currently exists.
The objective of this procurement is to acquire one Illumina Urinary Pathogen Identification/Antimicrobial Resistance Enrichment Kit for the Department of Clinical Investigation at Tripler Army Medical Center, with a scheduled delivery date of September 1, 2026. Interested vendors wishing to challenge the sole source basis have until 10:00 AM Pacific Daylight Time on April 22, 2026, to submit capability statements demonstrating their ability to provide equivalent equipment and preventive maintenance services. Capability statements must not exceed six pages in 10-point font and must be submitted as Microsoft Word or Adobe PDF attachments via email to Bobbie Dobberstein at bobbie.s.dobberstein.ctr@health.mil. Only vendors capable of providing sequencing supplies compatible with Government-owned MiSeq Systems and offering preventive maintenance support are eligible to challenge the sole source determination. Telephone requests or informal offers will not be accepted as part of the challenge process.
Notice text
Notice of Intent to Sole Source HT941026N0046
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES.
The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), intends to award a firm fixed price purchase order for Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP) for the Department of Clinical Investigation (DCI), Tripler Army Medical Center, Hawaii, in accordance with the Federal Acquisition Regulation Revolutionary (FAR) Overhaul 12.102(a):
- ILLUMINA, INC.
- 5200 Illumina Way
- San Diego, CA 92122
- UEI: KMW3CRWNAAF3
The North American Industry Classification System (NAICS) code for this requirement is 541714, Research and Technology in Biotechnology (except Nanobiotechnology); the business size standard is 1,000 (in employees). The Product Service Code (PSC) is 6550, Medical Equipment and Accessories and Supplies.
The objective of this sole source award is to procure one (1) Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP) for Tripler Army Medical Center. Illumina, Inc., is the only vendor that makes sequencing supplies for the DCI Government-owned MiSeq Systems. These sequencing supplies are specific for the Government-owned MiSeq System. There is no reasonable expectation of receiving quotes from two or more small businesses. The proposed acquisition strategy is to justify as an Other Than Full and Open procurement on a sole source basis.
- Delivery Date: 1 September 2026
- Delivery Location: Tripler Army Medical Center, Department of Clinical Investigation, 1 Jarrett White Road, Bldg 40, Tripler AMC, HI 96859-5000
Illumina, Inc., is the only source that can meet the Government’s minimum requirements to provide the requested UPIP for DCI at Tripler Army Medical Center, HI.
This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required equipment and preventive maintenance. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.
If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Bobbie Dobberstein at bobbie.s.dobberstein.ctr@health.mil.
The closing date for challenges is no later than 1000 Pacific Daylight Time, Wednesday, April 22, 2026.
NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.
Files
| File | Type | Posted |
|---|---|---|
| HT941026N0046 NOI TAMC UPIP Kits.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside | |
| Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center | National Institutes of Health | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside | |
| Intent to Sole Source - BD FACSCanto II instrument | National Institutes of Health | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity